David Moller has joined Sigilon Therapeutics to become the company’s chief scientific officer. Moller comes to the Cambridge, MA, drug
05
Jan
Category Archives: Uncategorized
05
Jan
The Stock Market Is on Autopilot
Click to view a price quote on CNTF. Click to research the Computer Hardware industry.
05
Jan
Biogen’s Jean-Paul Kress Joins Syntimmune as President and CEO
Jean-Paul Kress has been appointed president and CEO of Syntimmune. Kress will also serve as a director of the New
04
Jan
Boston Pharmaceuticals Appoints Peter Ho Chief Medical Officer
Peter Ho is joining Boston Pharmaceuticals as chief medical officer. He comes to the Cambridge, MA-based drug developer from Epizyme
03
Jan
OncoResponse Names Singal Chief Scientific Officer, Puri VP of R&D
OncoResponse has named Anil Singhal chief scientific officer of the Houston-based cancer drug developer. He comes to the company from
03
Jan
The January Effect Is on Time This Year
Click to view a price quote on SRNE. Click to research the Drugs industry.
03
Jan
Imbed Bio Snags $1.6M to Commercialize Infection-Preventing Dressing
Imbed Biosciences has raised a funding round of nearly $1.6 million, which the Fitchburg, WI-based startup plans to use to
02
Jan
FireEye Is My Must Buy Stock to Open 2018
Click to view a price quote on FEYE. Click to research the Computer Software & Services industry.
02
Jan
After Strong 2017, Biotechs & Medtechs Start ’18 with Venture, IPO News
Life science companies are continuing to raise cash, keeping pace with the financing trends of recent years. Fourth quarter figures
26
Dec
Can AI Startups Compete with Tech Giants?
If you happen to be a world-famous futurist, inventor, and entrepreneur, what would compel you to take a corporate job?